Receive $200 for creating an Interactive Brokers account using our link: Create IBKR account. Read our Interactive Brokers analysis

Ticker
SERA

Price
3.44
Stock movement down
-0.11 (-3.56%)
Company name
Sera Prognostics Inc
Exchange
(NASDAQ
,
Currency
USD
)
Sector
Healthcare >
Medical Devices
Market cap
110.54M
Ent value
129.13M
Price/Sales
1175.96
Price/Book
-
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
-
Forward P/E
-
PEG
-
EPS growth
-
1 year return (CAGR)
-55.85%
3 year return (CAGR)
-
5 year return (CAGR)
-
10 year return (CAGR)
-
Last updated: 2025-12-04

DIVIDENDS

SERA does not pay dividends or no data was received

iO Charts is a Seeking Alpha partner

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E-
Price to OCF-
Price to FCF-
Price to EBITDA-
EV to EBITDA-

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales1175.96
Price to Book-
EV to Sales1373.69

FINANCIALS

Per share

Loading...
Per share data
Current share count37.09M
EPS (TTM)-0.66
FCF per share (TTM)-0.53

Income statement

Loading...
Income statement data
Revenue (TTM)95.00K
Gross profit (TTM)-59.00K
Operating income (TTM)-36.97M
Net income (TTM)-32.63M
EPS (TTM)-0.66
EPS (1y forward)-0.68

Margins

Loading...
Margins data
Gross margin (TTM)-62.11%
Operating margin (TTM)-38918.95%
Profit margin (TTM)-34343.16%

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash4.08M
Net receivables14.00K
Total current assets44.49M
Goodwill0.00
Intangible assets939.00K
Property, plant and equipment9.34M
Total assets108.13M
Accounts payable1.04M
Short/Current long term debt2.45M
Total current liabilities23.50M
Total liabilities25.94M
Shareholder's equity82.18M
Net tangible assets0.00

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)-25.76M
Capital expenditures (TTM)457.00K
Free cash flow (TTM)-26.22M
Dividends paid (TTM)0.00

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity-39.70%
Return on Assets-30.17%
Return on Invested Capital-39.70%
Cash Return on Invested Capital-31.90%

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open3.15
Daily high3.30
Daily low2.96
Daily Volume26K
All-time high13.04
1y analyst estimate5.00
Beta0.98
EPS (TTM)-0.66
Dividend per share0.00
Ex-div date-
Next earnings date25 Mar 2026

Downside potential

Loading...
Downside potential data
SERAS&P500
Current price drop from All-time high-73.62%-0.89%
Highest price drop-88.57%-19.00%
Date of highest drop10 Jun 20258 Apr 2025
Avg drop from high-67.89%-2.49%
Avg time to new high-6 days
Max time to new high290 days89 days

iO Charts is a Seeking Alpha partner

COMPANY DETAILS
SERA (Sera Prognostics Inc) company logo
Marketcap
110.54M
Marketcap category
Small-cap
Description
Sera Prognostics, Inc., a women's health company, discovers, develops, and commercializes blood-based biomarker tests and predictive analytic products and services in the United States. The company develops the PreTRM test, a non-invasive blood test given to a pregnant woman for the prediction of the expectant mother's risk of delivering spontaneously. It is also developing a pipeline of novel blood-based biomarker tests for major pregnancy-related conditions, including time-to-birth, predictive analytics product, pregnancy risk prediction panel, preeclampsia, and fetal growth restriction. The company was incorporated in 2008 and is headquartered in Salt Lake City, Utah.
Employees
63
Investor relations
-
SEC filings
CEO
Country
USA
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...